You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PR088/#198  EZH2/EZH1 inhibitor tulmimetostat (CPI-0209): preliminary phase II results and first biomarker findings in patients with arid1a-mutant ovarian clear cell or endometrial carcinomas (OCCC/EC)

Article metrics

Article menu

Download PDFPDF

Featured Posters: Poster Rounds with the Professors
AS16. Screening/Early detection
PR088/#198  EZH2/EZH1 inhibitor tulmimetostat (CPI-0209): preliminary phase II results and first biomarker findings in patients with arid1a-mutant ovarian clear cell or endometrial carcinomas (OCCC/EC)
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to September 2024

AbstractFullPdf
Nov 20237507
Dec 202361010
Jan 20246007
Feb 20246505
Mar 20246508
Apr 202480016
May 20243207
Jun 20245404
Jul 20243105
Aug 202448015
Sep 20242704
Total598088